These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31318999)

  • 21. Robust expression of SIRT6 inhibits pulpitis via activation of the TRPV1 channel.
    Hu J; Chen W; Qiu Z; Lv H
    Cell Biochem Funct; 2020 Jul; 38(5):676-682. PubMed ID: 32236974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte elevated gene-1 participates in the production of pro-inflammatory cytokines in dental pulp cells via NF-κB signalling pathway.
    Wu H; He M; Yang R; Zuo Y; Bian Z
    Int Endod J; 2018 Oct; 51(10):1130-1138. PubMed ID: 29505090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The BMP and FGF pathways reciprocally regulate odontoblast differentiation.
    Parsegian K
    Connect Tissue Res; 2023 Jan; 64(1):53-63. PubMed ID: 35816114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation.
    Won JH; Im HT; Kim YH; Yun KJ; Park HJ; Choi JW; Lee KT
    Br J Pharmacol; 2006 May; 148(2):216-25. PubMed ID: 16520738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro.
    Xu ME; Xiao SZ; Sun YH; Ou-Yang Y; Zheng XX
    Acta Pharmacol Sin; 2006 Feb; 27(2):229-36. PubMed ID: 16412274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
    Yang P; Zhou Y; Xia Q; Yao L; Chang X
    Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide promotes adhesion and migration of murine dental papilla-derived MDPC-23 cells via TLR4.
    Park JH; Kwon SM; Yoon HE; Kim SA; Ahn SG; Yoon JH
    Int J Mol Med; 2011 Feb; 27(2):277-81. PubMed ID: 21125213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside-IV Alleviates Heat-Induced Inflammation by Inhibiting Endoplasmic Reticulum Stress and Autophagy.
    Dong Z; Zhou J; Zhang Y; Chen Y; Yang Z; Huang G; Chen Y; Yuan Z; Peng Y; Cao T
    Cell Physiol Biochem; 2017; 42(2):824-837. PubMed ID: 28641278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling.
    Kim MH; Kim SH; Yang WM
    PLoS One; 2014; 9(3):e92984. PubMed ID: 24676213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astragalus and Baicalein Regulate Inflammation of Mesenchymal Stem Cells (MSCs) by the Mitogen-Activated Protein Kinase (MAPK)/ERK Pathway.
    Zhu L; Liu YJ; Shen H; Gu PQ; Zhang L
    Med Sci Monit; 2017 Jul; 23():3209-3216. PubMed ID: 28667247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.
    Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN
    Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance.
    Jiang P; Ma D; Wang X; Wang Y; Bi Y; Yang J; Wang X; Li X
    Mol Cells; 2018 Mar; 41(3):244-255. PubMed ID: 29562733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of Astragaloside IV on ethanol-induced gastric mucosal injury in rats: Involvement of inflammation.
    Qin S; Huang K; Fang Z; Yin J; Dai R
    Int Immunopharmacol; 2017 Nov; 52():211-217. PubMed ID: 28942222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astragaloside exerts anti-photoaging effects in UVB-induced premature senescence of rat dermal fibroblasts through enhanced autophagy.
    Wen W; Chen J; Ding L; Luo X; Zheng X; Dai Q; Gu Q; Liu C; Liang M; Guo X; Liu P; Li M
    Arch Biochem Biophys; 2018 Nov; 657():31-40. PubMed ID: 30222953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
    Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
    Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.
    He CL; Yi PF; Fan QJ; Shen HQ; Jiang XL; Qin QQ; Song Z; Zhang C; Wu SC; Wei XB; Li YL; Fu BD
    Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):215-24. PubMed ID: 23171279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NRF2/HO-1 activation via ERK pathway involved in the anti-neuroinflammatory effect of Astragaloside IV in LPS induced microglial cells.
    Li C; Yang F; Liu F; Li D; Yang T
    Neurosci Lett; 2018 Feb; 666():104-110. PubMed ID: 29273400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.